Sunnymeath Asset Management’s Boston Scientific BSX Stock Holding History

Sunnymeath Asset Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$905K	Buy	41,850 +4,000	+11%	+$87.3K	1.27%	35
2016 Q3	$678K	Sell	37,850 -6,650	-15%	-$159K	1.48%	27
2016 Q2	$1.04M	Sell	44,500 -3,400	-7%	-$73.6K	1.52%	24
2016 Q1	$905K	Sell	47,900 -1,000	-2%	-$17.6K	1.38%	33
2015 Q4	$900K	Buy	+48,900	New	+$876K	1.43%	33

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Sunnymeath Asset Management's BSX Position: Q4 2016 in Review

Sunnymeath Asset Management increased its Boston Scientific (BSX) stake by 11% in Q4 2016, buying an estimated $87.3K and bringing the position to 41,850 shares worth $905K. The position accounts for 1.27% of the portfolio, ranked #35.

Sunnymeath Asset Management first reported a position in BSX in Q4 2015 and has held it in 5 quarters since. The position peaked at $1.04M in Q2 2016. 556 funds tracked by Wall St. Rank hold BSX as of Q4 2016.

Sunnymeath Asset Management held 41,850 shares of Boston Scientific worth $905K as of Q4 2016.
Sunnymeath Asset Management bought 4,000 Boston Scientific shares in Q4 2016, an estimated $87.3K.
Boston Scientific made up 1.27% of Sunnymeath Asset Management's portfolio in Q4 2016, its #35 holding.
Sunnymeath Asset Management first reported a position in Boston Scientific in Q4 2015 and has held it in 5 quarters since.
Sunnymeath Asset Management's Boston Scientific position peaked at $1.04M in Q2 2016.
556 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2016.

Based on Sunnymeath Asset Management's 13F filing for Q4 2016, filed 13 Jan 2017.